Exam 3 Flashcards
Mitosis; How long? Drugs that Target
o 1-7hrs
o Small % of cell cycle
Drugs
* Vinca alkaloids
* Taxols
G1 - 1st Gap Phase; What happens? Drugs that Target
o 7-170hrs
o RNA transcription
o Protein synthesis
Drugs
* L-Aspariginase (Elspar)
S-Phase; What happens? Drugs that Target
o 8-30hrs
o DNA synthesis in preparation for chromosomal duplication
o High metabolic rate
o High energy requirements
o Neoplastic cells have large nuclei
Drugs
* Antimetabolites
G2 - 2nd Gap Phase; What happens? Drugs that Target
o 1-4hrs
o pause prior to mitosis
o “checklist”
Drugs
* none
G0; What happens? Cells Involved
o Cells that are not actively cycling (replicating)
o Neurons, muscle cells do not re-enter cell cycle
o Hepatocytes normally do not re-enter cell cycle after maturity, but can
Fraction Cell Kill
o Chemo only kills fraction of cells not number of cells
o Very hard to completely eliminate (fraction of a fraction of a fraction)
Reasons for Chemo Failure
Dose limited by toxicity to patient
Drug resistance
* Failure to reach target
* Inactivation of drug
* Altered target
* Failure to undergo apoptosis
Response to Chemo
Complete
* Resolution of clinically apparent disease for at least 1mo
Partial
* Reduction of measurable tumor dimensions by at least 50% for 1 mo
Stable
* No change
* OR
* < 50% reduction in tumor dimensions
Progressive
* Growth of lesion
* OR
* appearance of new lesions
Resistance Criteria Based on 1 Dimension
Complete response:
o tumor no longer detectable,
Partial response:
o greater than 30% decrease in longest dimension of all target lesions
Stable disease:
o less than 30% decrease in the longest dimension of all target lesions, or less than 20% of tumor growth.
Progressive disease:
o greater than 20% increase in longest dimension was observed.
Biological response
o complete responders + Partial response + Stable disease
Chemo Dosing Based on Body Surface Area Vs Weight
Body Surface Area correlates w/
* Cardiac output
* Glomerular filtration rate
* Basal metabolic rate
Weight
* better for bone marrow stem cell turnover
Common Toxicities from Chemo Drugs
o BAGI
Bone marrow
* RBCs ->
* Neutrophils ->
* platelets
Alopecia
* Less common
GI
* Anorexia, nausea, V/D
* Premed w/ cisplatin to avoid nausea
* Lomustine at bed to allow sleep
* Doxorubicin for colitis associated nausea
Infertility
* Congenital malformations
Chemo Dosing & “cure” rate
o 20% dose reduction -> 50% reduction in cure rate
Chemo Safety Considerations
o Pregnant women should avoid
o Avoid contact w/ urine & feces 3 days post chemo
o PPE when prepping
Alkylating Agents for Chemo; MOA, Drugs, Use
MOA
* Interfere w/ DNA replication
* Form cross-bridges
* Mispairing
Drugs
* Cyclophosphamide
* Lomustine (can penetrate CNS)
* Chlorambucil
* Melphalan
Use
* Part of lymphoma treatment
* Mast cell tumors (lomustine)
* Histiocytic sarcoma (lomustine)
* Metronomic chemo
Cyclophosphamide, Lomustine, Chlorambucil Toxicities
Cyclophosphamide Toxicity
* BAG (worst at 7-14d)
* Sterile hemorrhagic cystitis
Lomustine Toxicity
* BAG
* Chronic neutropenia or thrombocytopenia
* Long-term hepatic, renal, & lung tox
Chlorambucil Toxicity
* BAG
* Used for pts that don’t tolerate Cyclophosphamide
* Rare animal still develops GI signs
Mitotic Inhibitors; Where from? MOA, Drugs, Use
o Initially from nature
MOA
* Bind microtubules ->
* interfere w/ cell division by interrupting the mitotic spindle
Drugs
* Vinca alkaloids (tubules don’t form): Vincristine (Oncovin®)
or Vinblastine
* Taxanes (tubules don’t break down): Paclitaxel
Use
* Component of lymphoma protocols (Vincristine)
* Vincristine alone: TVT
* Vinblastine-canine mast cell tumor, lymphoma
* Vinorelbine- concentrates in lung
* Injectable only
Vinca Alkaloids & Paclitaxel Toxicity
Vinca Alkaloids Toxicity
* BAG
* Peripheral neuropathy
* Dose must be reduced in MDR1 mutants
Paclitaxel Toxicity
* BAG
Antibiotics for Cancer; MOA, Drugs, Use
MOA
* Most from plants
* Many
* Interfere w/ DNA & RNA synthesis
* Intercalation into DNA
* Inhibition of topoisomerase
Drugs
* Doxorubicin (Adriamycin®)
* Mitoxantrone
* Bleomycin
Use
* Doxorubicin has high activity against a variety of tumors
* Newer analogues (Mitoxantrone) with less cardiotoxicity don’t seem to have same efficacy as doxorubicin
* Bleomycin is used for electrochemotherapy
Antibiotics for Cancer; Toxicity, Specific tox for Doxorubicin
- BAG
- Colitis
Doxorubicin
* Cumulative cardiac tox
* Possible renal damage in cats
* Severe tissue reaction if extravasated
* MDR1 substrate
Platinum Compounds; MOA, Drugs, Use
MOA
* Lab created
* Intra-strand cross-link DNA ->
* Interferes w/ RNA synthesis & DNA replication
Drugs
* Cisplatin
* Carboplatin
Use
* Osteosarcoma (Cisplatin is agent of choice but replaced by Carboplatin due decreased)
* Carcinomas- anal sac tumors, squamous cell carcinomas, nasal carcinomas
* Intralesional in equine sarcoids
Platinum Compounds; Toxicity, Specific Tox for Cisplatin
- BAG
- Carboplatin much safer in cats than Cisplatin
Cisplatin Toxicity
* Emetogenic
* Nephrotoxic
* Ototoxic
* Fatal pulmonary edema in cats
Antimetabolites for Cancer; MOA, Drugs, Use
MOA
* Man made
* Interfere with purine and pyrimidine synthesis and incorporation into DNA
Drugs & Use
* Methotrexate - older UW-Madison protocol for lymphoma
* 5-fluorouracil – carcinomas
* Azathioprine – immune mediated dz
* Cytosine arabinoside - Canine non-infectious encephalitis, Acute leukemia, Lymphoma in horses
Antimetabolites for Cancer; Specific Drug Toxicities
Methotrexate
* BAG
* Drug interactions due to protein bound
5-fluorouacil
* BAG
* Central neurotoxicity
Azathioprine
* BAG
* Myelosuppression in cats
Cytosine arabinoside
* BAG
L-asparaginase Enzyme; MOA, Toxicity, Use
MOA
* Inhibits protein synthesis
Toxicity
* Allergic reactions
* Pancreatitis
* Vomiting
Use
* Lymphoma
* Tumors in CNS
* NO IV
NSAIDs for Cancer; MOA, Drugs, Toxicity, Use
MOA
* COX-2 overexpressed in many tumors
* Enhance apoptosis
* Decrease tumor invasiveness
* Block angiogenesis
* Increase immune response by suppressing T-regulatory cells
Drugs
* Piroxicam
Toxicity
* GI ulceration (can add misoprostol)
* Renal (keep patients hydrated)
* Platelet dysfunction, bleeding
Use
* Transitional cell carcinoma
* Palliation of other tumors w/ metronomic chemotherapy